Akt, cellular senescence, and lifespan
Akt, cellular senescence, and lifespan
批准号:
7223511
负责人:
Nissim Hay
金额:
$30.32万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-15 至 2011-03-31
关键词:
AblationAddressAnimalsApoptosisCaenorhabditis elegansCaloric RestrictionCell AgingCell physiologyCellsCouplingCultured CellsDNA Microarray ChipDNA Microarray formatDistalDominant-Negative MutationEctopic ExpressionEnergy MetabolismEngineeringExhibitsExposure toGene ExpressionGene TargetingGenerationsGenesGeneticGenetic ModelsGoalsHomologous GeneHydrogen PeroxideIndividualKnock-outLaboratoriesLeadLongevityMammalsMediatingModelingMusNematodaNumbersOrganismOxidantsOxidative StressOxygen ConsumptionPTEN genePathway interactionsPersonal SatisfactionPhosphorylationPlayPreventionProcessProductionProtein IsoformsProtein OverexpressionProtein-Serine-Threonine KinasesProteinsProteomicsReactive Oxygen SpeciesRegulationResistanceRoleSignal PathwaySirolimusStressTestingage relatedcell growth regulationcell typeflyforkhead proteinglucose metabolismhuman FRAP1 proteininsulin signalinginterestsenescence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The coupling between lifespan and energy metabolism is well documented, and caloric restriction was shown to extend the lifespan of a wide spectrum of organisms. Genetic studies in nematodes and flies showed that impaired insulin signaling through PI3K and its downstream effector, the serine/threonine kinase, Akt, is associated with a decline in energy metabolism and an extended lifespan. In C. elegans, the most distal effector of insulin signaling that determines lifespan is the forkhead transcription factor, DAF-16, which is inactivated by Akt via phosphorylation. Thus, reduced Akt activity increases DAF-16 activity and thereby increases lifespan. Another conserved downstream effector of Akt, the target of rapamycin (TOR), was recently implicated in the regulation of lifespan both in nematodes and flies. However, the contribution of the PISK/Akt signaling pathway to longevity in mammals has not been thoroughly explored. In particular, there is no extant genetic evidence supporting a role for this pathway in mammalian lifespan. This may be due, in part, to the association of this pathway with an array of processes including, apoptosis, glucose metabolism, and differentiation, which complicate evaluating its role in modulating mammalian longevity. Our long-term goal is to determine whether Akt can regulate lifespan and sensitivity to oxidative stress in mice. The mouse has three Akt isoforms encoded by distinct genes (aktl, akt2, and akt3). We propose to take advantage of the availability of genetically engineered Akt-deficient mice generated in our laboratory. These animals lack individual akt genes, alone and in combination. They provide excellent genetic models for examination of the contributions of Akt activity and individual Akt isoforms to longevity and oxidative-stress-dependent aging and senescence. At the cellular level, we will expand on our initial observations that cells derived from Akt (knockout) KO mice exhibit lower basal levels of intracellular reactive oxygen species (ROS) than their wild-type counterparts, whereas cells expressing activated Akt generate higher ROS levels. These changes are associated with corresponding changes in both energy metabolism and oxygen consumption. We will elucidate the mechanisms whereby Akt activity regulates intracellular ROS abundance and the role of Akt in the regulation of cellular senescence. At the organism level, we will determine whether partial ablation of Akt activity caused by the loss of individual isoforms, alone or in combination, is sufficient to extend normal lifespan and confer resistance to oxidative stress in the mouse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hexokinase 2 and cancer therapy
-
批准号:10437024
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:10299101
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:10661677
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
The role of AMPK and CD36 in breast cancer tumorigenesis and metastasis
-
批准号:10377328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
The role of AMPK and CD36 in breast cancer tumorigenesis and metastasis
-
批准号:10618782
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:9763758
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:10454208
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:10618282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:9911969
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:10265395
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 in liver cancer
-
批准号:9195585
-
项目类别:
-
资助金额:$39.82万
-
财政年份:2016
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:8696773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:8512527
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:8330561
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:10171394
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7394933
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7584082
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7033151
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7795180
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
P13K/PTEN/Akt (PKB), Signaling and genesis of cancer
-
批准号:6866717
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2001
-
负责人:Nissim Hay
-
依托单位:
海外基金